Broccoli Sprout Extract.

Broccoli sprout extract mostly carries glucoraphanin, which has to be hydrolysed by myrosinase before sulforaphane exists. Ascorbate is the established cofactor that accelerates plant myrosinase, so it belongs with any glucoraphanin preparation that relies on enzymatic conversion rather than pre-formed sulforaphane.

The sulforaphane released from glucoraphanin activates Nrf2 and raises glutamate-cysteine ligase expression. NAC supplies the cysteine that enzyme needs, so the extract raises capacity while NAC supplies the material.

Phase two induction from broccoli sprout extract raises glutathione peroxidase and thioredoxin reductase expression, and both enzymes require selenocysteine at the active site. Selenium intake therefore determines whether the induced enzymes can function as built.

Broccoli sprout extract is standardised to glucoraphanin, which only becomes sulforaphane when myrosinase or gut bacteria cleave it, so conversion is the bottleneck. Adding preformed sulforaphane bypasses that step and gives a defined active dose.

Sulforaphane is conjugated to glutathione by glutathione S-transferase as its main handling route, which draws on the glutathione pool. Supplying glutathione supports that conjugation rather than duplicating the isothiocyanate.

Cysteine availability sets the rate of glutathione synthesis, and glutathione is both the conjugation partner for sulforaphane and one of the products its Nrf2 signalling raises. Cysteine feeds the pool at both ends.

Glutathione is a tripeptide of glutamate, cysteine and glycine, so glycine supply matters once cysteine is no longer the limit. It supports the same pool sulforaphane conjugation draws on.

Glutamine supplies the glutamate residue of glutathione, completing the three amino acid requirement alongside cysteine and glycine. It is a supporting substrate for the conjugation route.

NAD(P)H quinone oxidoreductase 1 is one of the phase II enzymes sulforaphane induces through Nrf2, and it is a flavoprotein requiring FAD. Riboflavin status therefore sets whether the induced enzyme can function.

The quinone reductase sulforaphane upregulates uses NAD(P)H as its electron donor, and niacin supplies the nicotinamide backbone of that cofactor. Induction without cofactor supply leaves the enzyme idle.

Molybdenum is the cofactor for sulfite oxidase, the enzyme that handles the sulfur load released as isothiocyanates and other sulfur compounds are processed. It supports the disposal end rather than the signalling end.

Lipoic acid also modifies Keap1 cysteines and releases Nrf2 to the nucleus, the same switch sulforaphane flips, so the two are additive on phase II enzyme induction. Because they overlap, the combined dose sets the response.

Curcumin is an electrophile that acts on Keap1 to raise Nrf2 driven transcription of phase II enzymes, overlapping with sulforaphane's mechanism. Combining them raises the total electrophilic signal on one pathway.

Pterostilbene raises Nrf2 dependent enzyme expression and has better oral availability than resveratrol because of its methoxy groups. It reinforces the same transcriptional response.

Resveratrol activates Nrf2 dependent phase II transcription alongside its sirtuin effects, so it overlaps partially with sulforaphane's route. The overlap is on the transcription step, not the conjugation step.

Glucarate slows intestinal beta-glucuronidase, which otherwise unhooks glucuronide conjugates and returns the parent compound to circulation. Sulforaphane induces the conjugating enzymes, and glucarate helps the conjugates leave.

Catechins such as EGCG also raise phase II enzyme expression through the Nrf2 route, so the effect overlaps with sulforaphane rather than adding a separate mechanism. Both are also handled by the same conjugation enzymes they induce.

Glucosinolate breakdown yields thiocyanate, which competes with iodide at the sodium iodide symporter and lowers iodide entry into the thyroid. At high glucosinolate intakes iodine supply is the offsetting factor to account for.

Quercetin and sulforaphane both act on the Keap1 and Nrf2 signalling step that induces phase II conjugating enzymes, though they modify it by different chemistry. Broccoli tissue carries flavonols natively, so the pairing occurs in the source plant. Documented mostly in cell systems, with cellular markers as the endpoint.

Luteolin influences the same antioxidant response signalling that isothiocyanates activate in laboratory models. The pairing is put together on mechanistic overlap. No human combination data is being asserted.

Apigenin is another dietary flavone with reported activity at the cellular antioxidant response element. The overlap with isothiocyanate signalling is at that transcriptional step. Read it as mechanistic rather than clinical.

Astaxanthin sits in the membrane and quenches lipid radicals directly, while sulforaphane acts indirectly by inducing the cell's own antioxidant enzymes. Direct scavenging and enzyme induction operate on different timescales, hours against days. That difference is the reason the two are combined.

Lycopene is a direct-acting carotenoid antioxidant, distinct in mechanism from an Nrf2 inducer. Both are frequently studied in the same dietary-pattern literature. The pairing is mechanistic complementarity rather than a tested combination.

Vitamin E terminates lipid peroxidation chains in the membrane; sulforaphane raises the cell's own glutathione and conjugating enzyme capacity. One acts on the chemistry directly, the other on the enzymes that handle it. Both endpoints in the supporting work are oxidative markers.

Pyridoxal 5-phosphate is the cofactor for cystathionine beta-synthase and cystathionine gamma-lyase, the transsulfuration enzymes that produce cysteine from homocysteine. Cysteine is the limiting substrate for glutathione, which conjugates sulforaphane for excretion. That places B6 upstream of the pathway that disposes of this ingredient.

B12 is the cofactor for methionine synthase, which regenerates methionine from homocysteine and controls how much homocysteine is available to enter transsulfuration toward cysteine. Cysteine supply sets glutathione synthesis, and glutathione conjugates isothiocyanates. The link is a cofactor chain rather than a trial finding.

5-methyltetrahydrofolate donates the methyl group that methionine synthase transfers to homocysteine, so folate status shapes the split between remethylation and transsulfuration. That split determines cysteine and therefore glutathione availability. Settled one-carbon biochemistry.

Betaine drives the folate-independent remethylation of homocysteine through betaine-homocysteine methyltransferase, an alternative route into the same cycle that feeds cysteine synthesis. It is relevant to any ingredient whose disposal runs on glutathione. This is established biochemistry.

S-adenosylmethionine is the methyl donor whose downstream product, homocysteine, feeds transsulfuration to cysteine and then glutathione. Glutathione conjugation is the first committed step in isothiocyanate disposal. The connection is a metabolic sequence.

Methionine is the dietary origin of the sulfur that becomes cysteine through the transsulfuration pathway, and cysteine limits glutathione synthesis. Sulforaphane is conjugated to glutathione before it is excreted. Adequate sulfur amino acid intake therefore sits behind the disposal route.

Extracts standardised to glucoraphanin rather than to sulforaphane rely on bacterial thioglucosidase activity for conversion when plant myrosinase has been inactivated. Individual sulforaphane recovery from such extracts varies several fold and tracks with the gut community. Supporting that community is directly relevant to what the product delivers.

Some lactobacilli hydrolyse glucosinolates in fermentation and laboratory settings. Whether an ingested strain performs the same conversion in a human colon is strain specific and not settled. The mechanism is documented; the clinical translation is not.

Inulin feeds the colonic bacteria that carry out glucosinolate hydrolysis when plant myrosinase is absent. That is an indirect route to more consistent sulforaphane recovery from a glucoraphanin extract. The endpoint is microbial capacity, measured in urinary metabolites.

Resistant starch shifts colonic fermentation and short-chain fatty acid output in the same compartment where conversion of glucoraphanin happens. It is a complementary substrate to inulin rather than an alternative. Mechanistic pairing.

Butyrate is the main colonocyte fuel and a histone deacetylase inhibitor; sulforaphane has reported activity at the same class of enzyme in cell systems. Both reach the colon from a whole-food brassica intake. The overlap is described in laboratory work, with cellular markers as the readout.

Silymarin and sulforaphane both influence hepatic conjugating enzyme expression in laboratory models, arriving there by different chemistry. The two are combined in liver-support formulas on that overlap. Human combination evidence is not being claimed.

Zinc is a structural component of copper-zinc superoxide dismutase and induces metallothionein, both of which sit in the same cellular antioxidant network that sulforaphane amplifies through enzyme induction. The two operate on separate arms of that network. Endpoint is enzyme activity, a marker.

Vitamin D acts through a nuclear receptor and sulforaphane through Keap1 and Nrf2, two distinct transcriptional routes that are studied together in cell models of epithelial function. The pairing is common in formulas but rests on separate mechanisms rather than a shared one. Read it as mechanistic.

Broccoli tissue carries phylloquinone, so a whole-sprout powder brings a small amount of vitamin K with it while a purified glucoraphanin extract largely does not. Anyone whose clotting is being managed medically should keep intake steady and raise it with their clinician. The point is compositional.

Whole-sprout powders contribute small amounts of plant minerals including magnesium, which supports normal muscle and nerve function. A standardised extract contributes far less. This distinction is about the material, not about a biological interaction.